Post-Authorization Safety Study Cohort Event Monitoring for Dengvaxia®, CYD-TDV Dengue Vaccine (DNG15-Post Authorisation safety Surveillance study)

06/08/2019
04/10/2024
EU PAS number:
EUPAS28947
Study
Finalised
Documents
Study protocol
Initial protocol
English (1.88 MB - PDF) View document
Study results
Study report
Study report
English (187.65 KB - PDF) View document
Other information